ORAL PHARMACEUTICAL MEDICINE FORMS CONTAINING ETEXILATE DAGIGATRAN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

摘要

The invention relates to oral pharmaceutical dosage forms of the active substance 3 - [(2 - {[4- (hexyloxycarbonylaminoiminomethyl) phenylamino] methyl} -1-methyl-1H-benzimidazole-5-carbonyl) pyridin-2-yl amino] ethylpropionate (dabigatran etexilate) and its pharmaceutically acceptable salts, in particular dabigatran etexilate methanesulfonate.